{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:18:41Z","timestamp":1791944321169,"version":"4.3.4"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:00:00Z","timestamp":1760832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD) is an autosomal recessive disease mostly caused by compound heterozygous pathogenic CYP21A2 variants. CYP21A2 promoter analysis is frequently not included in routine diagnostics, but could explain discrepancies in the usually good genotype-phenotype correlation. Here we investigate frequency and type of CYP21A2 promoter variants and their influence on 21-OHD phenotype.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Observational cohort study in a tertiary referral center and accredited genetic laboratory.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>CYP21A2 genotyping including promoter analysis was performed and clinical\/biochemical parameters were retrospectively collected in 1279 individuals undergoing routine diagnostic CYP21A2 genotyping.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We detected promoter variants in 89 individuals (7.0%). Of 207 patients with 21-OHD, 12.1% had promoter variants. A large conversion including the promoter (c.-126C&amp;gt;T, c.-113G&amp;gt;A, c.-110T&amp;gt;C, c.-103A&amp;gt;G) and p.(Pro31Leu) in exon 1 was found in 21 patients and led to a mostly simply virilizing phenotype when occurring in trans with another classic allele. Promoter variants were observed in CAH patients with only 1 known pathogenic variant (n = 4) and in clinically unaffected individuals with no other CYP21A2 variant (n = 6); conventional sequencing without the promoter region would not have suggested CAH or 21-OHD carrier status in these individuals (n = 10).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Non-benign promoter variants occur frequently in individuals with 21-OHD and clinically unaffected carriers. Promoter variants can aggravate clinical presentation in 21-OHD and can explain cases with discrepant genotype and phenotype. Inclusion of CYP21A2 promoter analysis in diagnostic procedures can improve accuracy of diagnosis, management and genetic counseling in patients with 21-OHD and their families.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvaf217","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:18:53Z","timestamp":1760617133000},"page":"563-574","source":"Crossref","is-referenced-by-count":2,"title":["Accurate diagnosis of congenital adrenal hyperplasia due to\n                    <i>CYP21A2<\/i>\n                    variants requires promoter analysis"],"prefix":"10.1093","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7972-7610","authenticated-orcid":false,"given":"Marie Helene","family":"Schernthaner-Reiter","sequence":"first","affiliation":[{"name":"Clinical Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna , Vienna 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Riedl","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pulmology, Allergology and Endocrinology, Department of Pediatrics, Medical University of Vienna , Vienna 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Obermayer-Pietsch","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University Graz , Graz 8036 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9265-7274","authenticated-orcid":false,"given":"Michael","family":"Krebs","sequence":"additional","affiliation":[{"name":"Clinical Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna , Vienna 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1918-1959","authenticated-orcid":false,"given":"Greisa","family":"Vila","sequence":"additional","affiliation":[{"name":"Clinical Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna , Vienna 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Kleinle","sequence":"additional","affiliation":[{"name":"Medical Genetics Center , Munich 80335 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7343-7455","authenticated-orcid":false,"given":"Harald","family":"Esterbauer","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Medical University of Vienna , Vienna 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Baumgartner-Parzer","sequence":"additional","affiliation":[{"name":"Clinical Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna , Vienna 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,19]]},"reference":[{"issue":"8","key":"2025111722563777600_lvaf217-B1","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1056\/NEJMra021561","article-title":"Congenital adrenal hyperplasia","volume":"349","author":"Speiser","year":"2003","journal-title":"N Engl J Med"},{"issue":"1-2","key":"2025111722563777600_lvaf217-B2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.mce.2003.09.013","article-title":"Inborn errors of adrenal steroidogenesis","volume":"211","author":"New","year":"2003","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"2025111722563777600_lvaf217-B3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1210\/edrv-9-3-295","article-title":"Molecular biology of steroid hormone synthesis","volume":"9","author":"Miller","year":"1988","journal-title":"Endocr Rev"},{"issue":"10","key":"2025111722563777600_lvaf217-B4","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41431-020-0653-5","article-title":"EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency","volume":"28","author":"Baumgartner-Parzer","year":"2020","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"2025111722563777600_lvaf217-B5","doi-asserted-by":"publisher","first-page":"103782","DOI":"10.1016\/j.ejmg.2019.103782","article-title":"21-Hydroxylase deficiency: mutational spectrum and genotype-phenotype relations analyses by next-generation sequencing and multiplex ligation-dependent probe amplification","volume":"63","author":"Turan","year":"2020","journal-title":"Eur J Med Genet"},{"issue":"4","key":"2025111722563777600_lvaf217-B6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1365-2265.2011.04123.x","article-title":"Steroid 21-hydroxylase gene mutational spectrum in 454 Argentinean patients: genotype-phenotype correlation in a large cohort of patients with congenital adrenal hyperplasia","volume":"75","author":"Marino","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"2025111722563777600_lvaf217-B7","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1073\/pnas.1300057110","article-title":"Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency","volume":"110","author":"New","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2025111722563777600_lvaf217-B8","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1365-2265.2005.02184.x","article-title":"Substitutions in the CYP21A2 promoter explain the simple-virilizing form of 21-hydroxylase deficiency in patients harbouring a P30L mutation","volume":"62","author":"Araujo","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"2025111722563777600_lvaf217-B9","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.1210\/jcem.86.10.7898","article-title":"Mutational spectrum of the steroid 21-hydroxylase gene in Austria: identification of a novel missense mutation","volume":"86","author":"Baumgartner-Parzer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025111722563777600_lvaf217-B10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1530\/eje.0.1490137","article-title":"Mutational spectrum of congenital adrenal hyperplasia in slovenian patients: a novel Ala15Thr mutation and Pro30Leu within a larger gene conversion associated with a severe form of the disease","volume":"149","author":"Dolzan","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2025111722563777600_lvaf217-B11","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1210\/jc.85.12.4562","article-title":"How a patient homozygous for a 30-kb deletion of the C4-CYP 21 genomic region can have a nonclassic form of 21-hydroxylase deficiency","volume":"85","author":"L'Allemand","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2025111722563777600_lvaf217-B12","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1210\/jc.2006-2163","article-title":"Microconversion between CYP21A2 and CYP21A1P promoter regions causes the nonclassical form of 21-hydroxylase deficiency","volume":"92","author":"Araujo","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2025111722563777600_lvaf217-B13","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025111722563777600_lvaf217-B14","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1210\/jc.2004-1728","article-title":"Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population","volume":"90","author":"Baumgartner-Parzer","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025111722563777600_lvaf217-B15","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1210\/jc.2002-021589","article-title":"A rare duplicated 21-hydroxylase haplotype and a de novo mutation: a family analysis","volume":"88","author":"Baumgartner-Parzer","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"1-2","key":"2025111722563777600_lvaf217-B16","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3109\/07435809509030452","article-title":"Divergence between genotype and phenotype in relatives of patients with the intron 2 mutation of steroid-21-hydroxylase","volume":"21","author":"Schulze","year":"1995","journal-title":"Endocr Res"},{"issue":"5","key":"2025111722563777600_lvaf217-B17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/hmg\/2.5.499","article-title":"Steroid 21-hydroxylase deficiency: two additional mutations in salt-wasting disease and rapid screening of disease-causing mutations","volume":"2","author":"Wedell","year":"1993","journal-title":"Hum Mol Genet"},{"issue":"4","key":"2025111722563777600_lvaf217-B18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/clinchem\/43.4.557","article-title":"Rapid screening method for detecting mutations in the 21-hydroxylase gene","volume":"43","author":"Oriola","year":"1997","journal-title":"Clin Chem"},{"issue":"10","key":"2025111722563777600_lvaf217-B19","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1210\/jc.2009-0487","article-title":"Duplications of the functional CYP21A2 gene are primarily restricted to Q318X alleles: evidence for a founder effect","volume":"94","author":"Kleinle","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025111722563777600_lvaf217-B20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"9","key":"2025111722563777600_lvaf217-B21","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41431-025-01905-x","article-title":"The role of untranslated region variants in Mendelian disease: a review","volume":"33","author":"Wieder","year":"2025","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"2025111722563777600_lvaf217-B22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13073-022-01073-3","article-title":"Recommendations for clinical interpretation of variants found in non-coding regions of the genome","volume":"14","author":"Ellingford","year":"2022","journal-title":"Genome Med"},{"issue":"5","key":"2025111722563777600_lvaf217-B23","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1210\/jc.2007-2701","article-title":"P.H62L, a rare mutation of the CYP21 gene identified in two forms of 21-hydroxylase deficiency","volume":"93","author":"Menassa","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2025111722563777600_lvaf217-B24","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1093\/nar\/26.8.1959","article-title":"The -104G nucleotide of the human CYP21 gene is important for CYP21 transcription activity and protein interaction","volume":"26","author":"Chin","year":"1998","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"2025111722563777600_lvaf217-B25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000075587","article-title":"Three novel mutations in Japanese patients with 21-hydroxylase deficiency","volume":"61","author":"Usui","year":"2004","journal-title":"Horm Res"},{"issue":"3","key":"2025111722563777600_lvaf217-B26","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1210\/jcem.85.3.6441","article-title":"Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany","volume":"85","author":"Krone","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025111722563777600_lvaf217-B27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nyas.12864","article-title":"A rare CYP21A2 mutation in a congenital adrenal hyperplasia kindred displaying genotype-phenotype nonconcordance","volume":"1364","author":"Khattab","year":"2016","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"2025111722563777600_lvaf217-B28","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1210\/jc.2005-1890","article-title":"Serum 21-Deoxycortisol, 17-Hydroxyprogesterone, and 11-deoxycortisol in classic congenital adrenal hyperplasia: clinical and hormonal correlations and identification of patients with 11beta-hydroxylase deficiency among a large group with alleged 21-hydroxylase deficiency","volume":"91","author":"Tonetto-Fernandes","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2025111722563777600_lvaf217-B29","doi-asserted-by":"publisher","first-page":"100598","DOI":"10.1016\/j.lanepe.2023.100598","article-title":"Epidemiology and diagnostic trends of congenital adrenal hyperplasia in Denmark: a retrospective, population-based study","volume":"28","author":"Berglund","year":"2023","journal-title":"Lancet Reg Health Eur"},{"issue":"2","key":"2025111722563777600_lvaf217-B30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1365-2265.2008.03356.x","article-title":"Variations in the promoter of CYP21A2 gene identified in a Chinese patient with simple virilizing form of 21-hydroxylase deficiency","volume":"70","author":"Zhang","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"16","key":"2025111722563777600_lvaf217-B31","doi-asserted-by":"publisher","first-page":"5889","DOI":"10.1073\/pnas.83.16.5889","article-title":"Affinity purification of sequence-specific DNA binding proteins","volume":"83","author":"Kadonaga","year":"1986","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvaf217\/64817988\/lvaf217.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/5\/563\/64817988\/lvaf217.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/5\/563\/64817988\/lvaf217.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T03:56:45Z","timestamp":1763438205000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/193\/5\/563\/8293134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,19]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvaf217","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,10,19]]}}}